(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
Year: 2019
Type: article
Abstract: BACKGROUND: Although recent studies provide insight into the molecular mechanisms of the effects of ketamine, the antidepressant mechanism of ketamine enantiomers and their metabolites is not fully understood. In view of the involvement of mechanisms other than the N-methyl-D-aspartate receptor in ketamine's action, we investigated the effects of (R)-ketamine, (S)-ketamine, (R)-norketamine [(R)-NK], (S)-NK, (2R,6R)-hydroxynorketamine [(2R,6R)-HNK], and (2S,6S)-HNK on monoaminergic neurotransmission in the prefrontal cortex of mice. METHODS: The extracellular monoamine levels in the prefrontal cortex were measured by in vivo microdialysis. RESULTS: (R)-Ketamine and (S)-ketamine acutely increased serotonin release in a dose-dependent manner, and the effect of (R)-ketamine was greater than that of (S)-ketamine. In contrast, (S)-ketamine caused a robust increase in dopamine release compared with (R)-ketamine. Both ketamine enantiomers increased noradrenaline release, but these effects did not differ. (2R,6R)-HNK caused a slight but significant increase in serotonin and noradrenaline but not dopamine release. (S)-NK increased dopamine and noradrenaline but not serotonin release. Differential effects between (R)-ketamine and (S)-ketamine were also observed in a lipopolysaccharide-induced model of depression. An α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor antagonist, 2,3-dioxo-6-nitro-1,2,3,4- tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX), attenuated (S)-ketamine-induced, but not (R)-ketamine-induced serotonin release, whereas NBQX blocked dopamine release induced by both enantiomers. Local application of (R)-ketamine into the prefrontal cortex caused a greater increase in prefrontal serotonin release than that of (S)-ketamine. CONCLUSIONS: (R)-Ketamine strongly activates the prefrontal serotonergic system through an AMPA receptor-independent mechanism. (S)-Ketamine-induced serotonin and dopamine release was AMPA receptor-dependent. These findings provide a neurochemical basis for the underlying pharmacological differences between ketamine enantiomers and their metabolites.
DOI: 10.1093/ijnp/pyz041
Institutions: The University of Osaka, Kanazawa University, University of Fukui, Chiba University, Hamamatsu University School of Medicine, Center for Forensic Mental Health, Chiba University, Institute for Open and Transdisciplinary Research Initiatives, Molecular Research Center for Children's Mental Development
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: ketamine enantiomers, (R)-ketamine, esketamine, ketamine metabolites, norketamine, hydroxynorketamine, serotonin release, dopamine release, noradrenaline release, prefrontal cortex, AMPA receptors, NBQX, antidepressant mechanism, lipopolysaccharide-induced depression, monoaminergic neurotransmission
Open Access status: gold
Estimated APC paid: $2,693
Awards: Drug discovery research targeting the novel regulation of prefrontal dopaminergic system by the functional interaction between the sigma1 and serotonin1A receptors, G1279687301, G1515086623, A novel whole-brain imaging analysis for the pathogenesis and therapeutic mechanisms of psychiatric disorders, G2454511920, G2518072567, G2520678962, G2528120606, Development of single cell-based technologies for iPSC-neurons from patients with schizophrenia, G5375198244, G6676166977, G7402435851, G756428506, G7981696003, Advanced Animal Model Support, G8698444300
OpenAlex ID: W2966617845
